NICE rebuffs PCTs’ call to help identify more areas for savings

By 2009-07-30T00:00:00

Andrew Dillon the chief executive of the National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

The National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here